Press Release

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 20, 2013--
AVEO Oncology (NASDAQ: AVEO) today announced that David Johnston, chief
financial officer, is scheduled to present at the 2013 RBC Capital
Markets’ Healthcare Conference on Wednesday, February 27, 2013 at 2:00
p.m. (ET) in New York City.

A live webcast of AVEO’s presentation can be accessed by visiting the
investors section of the company’s website at investor.aveooncology.com.
A replay of the webcast will be archived on the AVEO website for two
weeks following the presentation.

About AVEO

AVEO Oncology (NASDAQ: AVEO) is a cancer therapeutics company committed
to discovering, developing and commercializing targeted therapies to
impact patients’ lives. AVEO’s proprietary Human Response PlatformTM
provides the company unique insights into cancer biology and is being
leveraged in the discovery and clinical development of its cancer
therapeutics. For more information, please visit the company’s website
at www.aveooncology.com.